Home

Robert A Stewart

CIK 1476493 · President and CEO · last filed 2026-01-27

Robert A Stewart is a President and CEO who has filed 33 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing, for CRMD, was dated Jan 27, 2026. Across all open-market trades the lifetime net is +$246.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.4M across reported positions. 13 SEC filings were submitted jointly with Actavis plc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.41M

Companies

5

Total Filings

33

Lifetime Open-Market Net

$246.4K

Filer Profile

Reported Address
360 MT. KEMBLE AVENUE
MORRISTOWN, NJ 07960
Related Filers
Actavis plc — 13 joint filings, latest 2018-01-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRMD Director 66,453 $7.83 $520.0K $43.7K 6 2026-01-27
AMRX President and CEO 100,277 $17.01 $1.71M $202.6K 4 2019-05-09
Allergan plc (AGN) Delisted Chief Operating Officer 66,650 — — $0 5 2018-01-02
ACT Chief Operating Officer 44,225 $49.43 $2.19M $0 2 2015-03-09
Actavis, Inc. (WPI) Delisted Pres-Global Operations 77,154 — — $0 7 2012-11-02

Recent Filings

33 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-27 CRMD Grant (A) +30,453 $0 EDGAR
2025-01-22 CRMD Grant (A) +25,000 $0 EDGAR
2024-03-20 CRMD Grant (A) — $0 EDGAR
2023-05-18 CRMD Buy (P) +10,000 $43.7K EDGAR
2023-05-17 CRMD Grant (A) +10,000 $43.7K EDGAR
2023-04-17 CRMD Grant (A) — $0 EDGAR
2019-05-09 AMRX Mixed +61,668 -$290.4K EDGAR
2019-03-12 AMRX Buy (P) +17,000 $202.6K EDGAR
2019-03-05 AMRX Grant (A) — $0 EDGAR
2018-05-09 AMRX Grant (A) — $0 EDGAR
Showing 1–10 of 33
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.